These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 420220)
21. The preparation and use of a formulary in a provincial hospital. Baker P Med J Zambia; 1979; 13(5):96-7. PubMed ID: 263384 [No Abstract] [Full Text] [Related]
23. Cost containment through restriction of cephalosporins. Britton HL; Schwinghammer TL; Romano MJ Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168 [TBL] [Abstract][Full Text] [Related]
24. Effect of aminoglycoside-use restrictions on drug cost. DeTorres OH; White RE Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070 [TBL] [Abstract][Full Text] [Related]
25. Formulary management to reduce cost: P & T committee strategies. Roberts MJ; Summerfield MR Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289 [TBL] [Abstract][Full Text] [Related]
26. Criteria-based DUE aids in selection of preferred agent. Drea EJ Hosp Formul; 1991 Nov; 26 Suppl D():25-7. PubMed ID: 10136562 [TBL] [Abstract][Full Text] [Related]
27. Cephalosporins: use review and cost analysis. Noel MW; Paxinos J Am J Hosp Pharm; 1978 Aug; 35(8):933-5. PubMed ID: 677139 [TBL] [Abstract][Full Text] [Related]
28. Reducing the number of formulary theophylline preparations. Anandan JV Am J Hosp Pharm; 1981 Apr; 38(4):511-3. PubMed ID: 7282676 [TBL] [Abstract][Full Text] [Related]
29. An approach to regulating cephalosporin use and costs. Ryan JL; Francese J Hosp Formul; 1980 Sep; 15(9):674-6. PubMed ID: 10248357 [No Abstract] [Full Text] [Related]
30. Effect of pharmacists' clinical interventions on nonformulary drug use. Packer LA; Mahoney CD; Rich DS; Jeffrey LP Am J Hosp Pharm; 1986 Jun; 43(6):1461-6. PubMed ID: 3728481 [TBL] [Abstract][Full Text] [Related]
31. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital. Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432 [TBL] [Abstract][Full Text] [Related]
32. Cost effectiveness of an enteral products formulary. Durfee DD; Skinner-Domet VM Am J Hosp Pharm; 1984 Nov; 41(11):2352-4. PubMed ID: 6439034 [TBL] [Abstract][Full Text] [Related]
33. Pharmacoeconomic analysis in formulary decisions: an international perspective. Johnson JA; Bootman JL Am J Hosp Pharm; 1994 Oct; 51(20):2593-8. PubMed ID: 7847423 [TBL] [Abstract][Full Text] [Related]
35. The long-term value of the selected list as a method of controlling drug costs in a district general hospital. Upton DR; Holmes GK; Fox PD; Cullen AM; Poston JW Health Trends; 1989 Feb; 21(1):26-9. PubMed ID: 10292126 [TBL] [Abstract][Full Text] [Related]
36. Antimicrobial formulary management: a case study in a teaching hospital. Wright DB Pharmacotherapy; 1991; 11(1 ( Pt 2)):27S-31S. PubMed ID: 2011570 [TBL] [Abstract][Full Text] [Related]
37. Evaluating a restrictive formulary system by assessing nonformulary-drug requests. Green JA; Chawla AK; Fong PA Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350 [TBL] [Abstract][Full Text] [Related]
38. Cephalosporin-use restrictions in teaching hospitals. McCloskey WW; Johnson PN; Jeffrey LP Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437 [TBL] [Abstract][Full Text] [Related]
39. The treatment of seasonal allergic rhinitis: cost implications of pharmacotherapy for managed care. Trotter JP Manag Care Interface; 2000 Jan; 13(1):60-2. PubMed ID: 10747693 [TBL] [Abstract][Full Text] [Related]